FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381598991> ?p ?o ?g. }

• W4381598991 endingPage "2116" @default.
• W4381598991 startingPage "2116" @default.
• W4381598991 abstract "Acknowledging the lack of an effective screening modality for ovarian cancer, the Ovarian Cancer Research Alliance (OCRA) recommends that women undergoing pelvic surgeries for benign conditions such as hysterectomy, cysts, tubal ligations, and endometriosis consider having their fallopian tubes removed. In a consensus statement1 issued on January 30, 2023, the organization cited the United Kingdom Collaborative Trial of Ovarian Cancer Screening, which found that general population screening did not significantly reduce ovarian and tubal cancer deaths.2 Not only did screening average-risk women with cancer antigen 125 and ultrasound not reduce ovarian cancer mortality, the results also showed that identifying stage I or stage II cancers did not affect mortality in many women. Elise C. Kohn, MD, head of gynecologic cancer therapeutics in the Cancer Therapy Evaluation Program at the National Cancer Institute, qualifies the OCRA statement, adding, “The cells of origin in most, if not all, high-grade serous ovarian cancer are in the distal end of the fallopian tube, or fimbria.” The Society of Gynecologic Oncology also endorsed OCRA’s recommendation. Still, Dr Kohn notes that there are limited data on the value of removing tubes in women who are not at high risk for ovarian cancer. “Because we have no good screening modality for ovarian cancer, we need to research other ways of reducing risk,” she says. “We’re trying to parse out recommendations for the general population and for highrisk women.” The previous standard of care for women at high risk for the disease based on BRCA1 and BRCA2 mutations was to remove the uterus, tubes, and ovaries; this reduced their risk of ovarian cancer by approximately 95%, notes Dr Kohn. More recently, clinicians began removing only the tubes and ovaries in these patients, and now they are postponing ovary removal until women are past their child-bearing years. The main questions that researchers still need to address for the general population are whether it is safe to remove fallopian tubes and whether doing so reduces the lifetime risk of ovarian cancer. Preliminary results from a 2014 British Columbia study have shown that it is both safe and feasible,3 although long-term data are needed for delaying ovary removal in high-risk women, Dr Kohn notes. She adds that none of the results in this area have been randomized and that a number of registry studies are underway. Dr Kohn notes that two prospective clinical trials are assessing the risk-reducing effects of fallopian tube removal: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer (NCT04251052 at ClinicalTrials.gov) and Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk-Reducing Salpingo-Oophorectomy in High Risk-Women to Assess the Safety of Prevention—US Cohort Study (NCT05287451 at ClinicalTrials.gov). Encouraging patients to know their risk and the symptoms of ovarian cancer. Promoting genetic testing to at-risk populations. Encouraging those undergoing pelvic surgeries for benign conditions to consider having their fallopian tubes removed. Educating women or those born with ovaries about the symptoms of ovarian cancer. Educating patients to ensure that every person diagnosed with ovarian cancer is seen by a gynecologic oncologist and has access to the best standard of care. Encouraging cascade testing for patients’ family members when a genetic risk mutation is discovered. Promoting consideration of participation in clinical trials." @default.
• W4381598991 created "2023-06-23" @default.
• W4381598991 creator A5062959891 @default.
• W4381598991 date "2023-06-22" @default.
• W4381598991 modified "2023-10-12" @default.
• W4381598991 title "OCRA encourages fallopian tube removal for women undergoing pelvic surgeries for benign conditions" @default.
• W4381598991 cites W2095085832 @default.
• W4381598991 cites W3162975920 @default.
• W4381598991 doi "https://doi.org/10.1002/cncr.34902" @default.
• W4381598991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37345668" @default.
• W4381598991 hasPublicationYear "2023" @default.
• W4381598991 type Work @default.
• W4381598991 citedByCount "0" @default.
• W4381598991 crossrefType "journal-article" @default.
• W4381598991 hasAuthorship W4381598991A5062959891 @default.
• W4381598991 hasBestOaLocation W43815989911 @default.
• W4381598991 hasConcept C121608353 @default.
• W4381598991 hasConcept C126322002 @default.
• W4381598991 hasConcept C131872663 @default.
• W4381598991 hasConcept C141071460 @default.
• W4381598991 hasConcept C143998085 @default.
• W4381598991 hasConcept C150173356 @default.
• W4381598991 hasConcept C2775883341 @default.
• W4381598991 hasConcept C2777088508 @default.
• W4381598991 hasConcept C2779065011 @default.
• W4381598991 hasConcept C2779076696 @default.
• W4381598991 hasConcept C2779494336 @default.
• W4381598991 hasConcept C2779522080 @default.
• W4381598991 hasConcept C2780427987 @default.
• W4381598991 hasConcept C2908647359 @default.
• W4381598991 hasConcept C29456083 @default.
• W4381598991 hasConcept C2986817661 @default.
• W4381598991 hasConcept C71924100 @default.
• W4381598991 hasConcept C99454951 @default.
• W4381598991 hasConceptScore W4381598991C121608353 @default.
• W4381598991 hasConceptScore W4381598991C126322002 @default.
• W4381598991 hasConceptScore W4381598991C131872663 @default.
• W4381598991 hasConceptScore W4381598991C141071460 @default.
• W4381598991 hasConceptScore W4381598991C143998085 @default.
• W4381598991 hasConceptScore W4381598991C150173356 @default.
• W4381598991 hasConceptScore W4381598991C2775883341 @default.
• W4381598991 hasConceptScore W4381598991C2777088508 @default.
• W4381598991 hasConceptScore W4381598991C2779065011 @default.
• W4381598991 hasConceptScore W4381598991C2779076696 @default.
• W4381598991 hasConceptScore W4381598991C2779494336 @default.
• W4381598991 hasConceptScore W4381598991C2779522080 @default.
• W4381598991 hasConceptScore W4381598991C2780427987 @default.
• W4381598991 hasConceptScore W4381598991C2908647359 @default.
• W4381598991 hasConceptScore W4381598991C29456083 @default.
• W4381598991 hasConceptScore W4381598991C2986817661 @default.
• W4381598991 hasConceptScore W4381598991C71924100 @default.
• W4381598991 hasConceptScore W4381598991C99454951 @default.
• W4381598991 hasIssue "14" @default.
• W4381598991 hasLocation W43815989911 @default.
• W4381598991 hasLocation W43815989912 @default.
• W4381598991 hasOpenAccess W4381598991 @default.
• W4381598991 hasPrimaryLocation W43815989911 @default.
• W4381598991 hasRelatedWork W1988645453 @default.
• W4381598991 hasRelatedWork W2003635697 @default.
• W4381598991 hasRelatedWork W2054107082 @default.
• W4381598991 hasRelatedWork W2063654850 @default.
• W4381598991 hasRelatedWork W2125221049 @default.
• W4381598991 hasRelatedWork W2740468878 @default.
• W4381598991 hasRelatedWork W2759697580 @default.
• W4381598991 hasRelatedWork W3208449664 @default.
• W4381598991 hasRelatedWork W4321088342 @default.
• W4381598991 hasRelatedWork W88698947 @default.
• W4381598991 hasVolume "129" @default.
• W4381598991 isParatext "false" @default.
• W4381598991 isRetracted "false" @default.
• W4381598991 workType "article" @default.